Evidence map›Paper›PMID 32929862›Full record

ArticleEMBO reports2020

Exploring GPCR-arrestin interfaces with genetically encoded crosslinkers.

Thore Böttke, Stefan Ernicke, Robert Serfling, Christian Ihling, Edyta Burda, Vsevolod V Gurevich, Andrea Sinz, Irene Coin

Open access · hybridAbstract read
In one paragraph

Article in EMBO reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Internal Ubiquitin Electrophiles for Covalent Trapping and Inhibition of Deubiquitinases.Chembiochem : a European journal of chemical biology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. GPCR-dependent and -independent arrestin signaling.Trends in pharmacological sciences · 2024
    Review
  13. Arrestins: A Small Family of Multi-Functional Proteins.International journal of molecular sciences · 2024
    Review
  14. Review
  15. Pharmacological reviews · 2023
    Review
  16. Article
  17. Article
  18. Genetically encoded crosslinkers to address protein-protein interactions.Protein science : a publication of the Protein Society · 2023
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Thore BöttkeInstitute of Biochemistry, Faculty of Life Sciences, University of Leipzig, Leipzig, Germany.ORCID 0000-0003-4817-9487
Stefan ErnickeInstitute of Biochemistry, Faculty of Life Sciences, University of Leipzig, Leipzig, Germany.
Robert SerflingInstitute of Biochemistry, Faculty of Life Sciences, University of Leipzig, Leipzig, Germany.
Christian IhlingInstitute of Pharmacy, Department of Pharmaceutical Chemistry and Bioanalytics, Charles Tanford Protein Center, Martin Luther University Halle-Wittenberg, Halle/Saale, Germany.
Edyta BurdaInstitute of Pharmacy, Faculty of Medicine, University of Leipzig, Leipzig, Germany.
Vsevolod V GurevichDepartment of Pharmacology, Vanderbilt University, Nashville, TN, USA.ORCID 0000-0002-3950-5351
Andrea SinzInstitute of Pharmacy, Department of Pharmaceutical Chemistry and Bioanalytics, Charles Tanford Protein Center, Martin Luther University Halle-Wittenberg, Halle/Saale, Germany.
Irene CoinInstitute of Biochemistry, Faculty of Life Sciences, University of Leipzig, Leipzig, Germany.ORCID 0000-0002-7722-004X
Leipzig University · DEMartin Luther University Halle-Wittenberg · DEVanderbilt University · US

Funding

STRUCTURE/FUNCTION STUDIES OF VISUAL ARRESTINR01EY011500 · NEI · VANDERBILT UNIVERSITY · PI T M Iverson · 1997 to 2026
$12.3M
Targeted Engineering of Designer Arrestins to Regulate Cell SignalingR35GM122491 · NIGMS · VANDERBILT UNIVERSITY · PI GUREVICH, VSEVOLOD V. · 2017 to 2021
$2.6M
Deutsche Forschungsgemeinschaft (DFG) CO822/2-1Deutsche Forschungsgemeinschaft (DFG) CO822/3-1Deutsche Forschungsgemeinschaft (DFG) Si867/15-2Max-Buchner-Forschungsstiftung 3456NEI NIH HHS R01 EY011500NIGMS NIH HHS R35 GM122491
6 · The paper itself

Abstract

β-arrestins (βarr1 and βarr2) are ubiquitous regulators of G protein-coupled receptor (GPCR) signaling. Available data suggest that β-arrestins dock to different receptors in different ways. However, the structural characterization of GPCR-arrestin complexes is challenging and alternative approaches to study GPCR-arrestin complexes are needed. Here, starting from the finger loop as a major site for the interaction of arrestins with GPCRs, we genetically incorporate non-canonical amino acids for photo- and chemical crosslinking into βarr1 and βarr2 and explore binding topologies to GPCRs forming either stable or transient complexes with arrestins: the vasopressin receptor 2 (rhodopsin-like), the corticotropin-releasing factor receptor 1, and the parathyroid hormone receptor 1 (both secretin-like). We show that each receptor leaves a unique footprint on arrestins, whereas the two β-arrestins yield quite similar crosslinking patterns. Furthermore, we show that the method allows defining the orientation of arrestin with respect to the GPCR. Finally, we provide direct evidence for the formation of arrestin oligomers in the cell.

Indexed as

ArrestinArrestinsbeta-ArrestinsReceptors, G-Protein-CoupledSignal TransductionArrestinArrestinsbeta-ArrestinsReceptors, G-Protein-Coupledgenetically encoded crosslinkersGPCR-arrestin complexesG protein-coupled receptorlive cellsβ-arrestins

Identifiers

PMID32929862
PMCPMC7645262
OpenAlexW3085998057

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.